{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:16:07Z","timestamp":1783304167707,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pneumonia is a common infection at the end of life, yet the benefits of antibiotics for symptom relief or prolonged survival remain uncertain. This study aimed to investigate physicians\u2019 attitudes and factors influencing antibiotic prescription in aspiration pneumonia in frail older patients in palliative care settings across Switzerland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A survey was conducted among physicians practicing in internal medicine, geriatrics and family medicine, in hospital or ambulatory settings across Switzerland\u2019s three linguistic regions. Participants were randomized to receive one of three clinical vignettes describing a geriatric patient with aspiration pneumonia, with variations in advance directives, functional dependency and dementia status. They were asked whether they would prescribe antibiotics and to explain their reasoning. The survey also collected participant demographics, including age, linguistic region, practice setting and palliative care experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 195 participants, 22.1% opted to prescribe antibiotics. The primary reason for prescribing antibiotics was to alleviate dyspnea. Physicians were significantly more likely to prescribe antibiotics for patients with better functional status. Notably, 76.4% believed withholding antibiotics could shorten life, while 77.9% did not think antibiotics improved comfort. Physicians practicing in French-speaking regions were more likely to prescribe antibiotics than their counterparts in German- and Italian-speaking regions (33.7% vs 13.8% and 11.1% respectively.) Age, practice setting and palliative care experience were not significantly associated with prescribing behaviour. Additionally, 77.9% of physicians stated that they would modify their decision if the patient\u2019s family disagreed with their initial choice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight ongoing uncertainties and cultural variations in antibiotic prescribing practices at the end of life, highlighting the need for clinical decision-support tools and educational resources directed not only at physicians, but also at nursing teams, families, and caregivers. In the context of an aging population and rising antimicrobial resistance, a deeper understanding of the factors influencing antibiotic use in palliative care is essential to inform the development of targeted antimicrobial stewardship interventions aligned with patient values and palliative care goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-026-07477-9","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:56:44Z","timestamp":1778561804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic prescription for older patients in end-of-life care: a randomized survey among physicians in Switzerland"],"prefix":"10.1186","volume":"26","author":[{"given":"L.","family":"Papasokrati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pautex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vayne-Bossert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Prendki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"7477_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejim.2024.01.009","volume":"124","author":"J Alves","year":"2024","unstructured":"Alves J, Prendki V, Chedid M, Yahav D, Bosetti D, Rello J, et al. Challenges of antimicrobial stewardship among older adults. Eur J Intern Med. 2024;124:5\u201313. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.009.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"7477_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3947\/ic.2024.0088","volume":"57","author":"MJ Alwazzeh","year":"2025","unstructured":"Alwazzeh MJ. End-of-life infections and the dilemma of emerging antimicrobial resistance: a scoping review. Infect Chemother. 2025;57(1):1\u201312. https:\/\/doi.org\/10.3947\/ic.2024.0088.","journal-title":"Infect Chemother"},{"key":"7477_CR3","unstructured":"Antimicrobial consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report for 2023. 2024. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-consumption-eueea-esac-net-annual-epidemiological-report-2023."},{"issue":"4","key":"7477_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.idc.2017.07.009","volume":"31","author":"A Baghban","year":"2017","unstructured":"Baghban A, Juthani-Mehta M. Antimicrobial use at the end of life. Infect Dis Clin North Am. 2017;31(4):639\u201347. https:\/\/doi.org\/10.1016\/j.idc.2017.07.009.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"7477_CR5","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u201377. https:\/\/doi.org\/10.1093\/cid\/ciw118.","journal-title":"Clin Infect Dis"},{"key":"7477_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31634","author":"E Campoa","year":"2022","unstructured":"Campoa E, Teixeira J, Luz P, Magalhaes J. End-of-life antibiotherapy: factors associated with prescription. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.31634.","journal-title":"Cureus"},{"key":"7477_CR7","doi-asserted-by":"publisher","first-page":"c4467","DOI":"10.1136\/bmj.c4467","volume":"341","author":"R Cooper","year":"2010","unstructured":"Cooper R, Kuh D, Hardy R, Mortality Review Group. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010;341:c4467. https:\/\/doi.org\/10.1136\/bmj.c4467.","journal-title":"BMJ"},{"key":"7477_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.10.026","volume":"114","author":"DH Crispim","year":"2022","unstructured":"Crispim DH, da Silva IO, de Carvalho RT, Levin AS. End-of-life use of antibiotics: a survey on how doctors decide. Int J Infect Dis. 2022;114:219\u201325. https:\/\/doi.org\/10.1016\/j.ijid.2021.10.026.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"7477_CR9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1017\/ice.2019.194","volume":"40","author":"R Datta","year":"2019","unstructured":"Datta R, Topal J, McManus D, Dembry LM, Quagliarello V, Juthani-Mehta M. Perspectives on antimicrobial use at the end of life among antibiotic stewardship programs: a survey of the society for healthcare epidemiology of america research network. Infect Control Hosp Epidemiol. 2019;40(9):1074\u20136. https:\/\/doi.org\/10.1017\/ice.2019.194.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"7477_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tim.2022.12.010","volume":"31","author":"F Dionisio","year":"2023","unstructured":"Dionisio F, Baquero F, Fuertes M. Psychological and cultural factors influencing antibiotic prescription. Trends Microbiol. 2023;31(6):559\u201370. https:\/\/doi.org\/10.1016\/j.tim.2022.12.010.","journal-title":"Trends Microbiol"},{"issue":"5","key":"7477_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/jpm.2009.0299","volume":"13","author":"GM Downing","year":"2010","unstructured":"Downing GM, Lesperance M, Lau F, Yang J. Survival implications of sudden functional decline as a sentinel event using the palliative performance scale. J Palliat Med. 2010;13(5):549\u201357. https:\/\/doi.org\/10.1089\/jpm.2009.0299.","journal-title":"J Palliat Med"},{"issue":"4","key":"7477_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.medmal.2020.10.013","volume":"51","author":"M Durand","year":"2021","unstructured":"Durand M, Forestier E, Gras Aygon C, Sirvain S, De Wazi\u00e8res B, Bernard L, et al. Determinants of doctors\u2019 antibiotic prescriptions for patients over 75 years old in the terminal stage of palliative care. Infect Dis Now. 2021;51(4):340\u20135. https:\/\/doi.org\/10.1016\/j.medmal.2020.10.013.","journal-title":"Infect Dis Now"},{"issue":"e2","key":"7477_CR13","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1136\/bmjspcare-2020-002558","volume":"14","author":"J Fairweather","year":"2024","unstructured":"Fairweather J, Cooper L, Sneddon J, Seaton RA. Antimicrobial use at the end of life: a scoping review. BMJ Support Palliat Care. 2024;14(e2):e1873. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002558.","journal-title":"BMJ Support Palliat Care"},{"issue":"11","key":"7477_CR14","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1017\/ice.2019.203","volume":"40","author":"R Fedorowsky","year":"2019","unstructured":"Fedorowsky R, Bachner YG, Borer A, Ciobotaro P, Kushnir T. Use of antibiotics among end-of-life hospitalized patients with advanced directives: status examination and association with infectious disease consultation and physician burnout. Infect Control Hosp Epidemiol. 2019;40(11):1222\u20138. https:\/\/doi.org\/10.1017\/ice.2019.203.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"7477_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cmi.2019.04.021","volume":"25","author":"E Forestier","year":"2019","unstructured":"Forestier E, Roubaud-Baudron C, Fraisse T, Patry C, Gavazzi G, Hoen B, et al. Comprehensive geriatric assessment in older patients suffering from infective endocarditis. A prospective multicentric cohort study. Clin Microbiol Infect. 2019;25(10):1246\u201352. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.021.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"7477_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17476348.2025.2479613","volume":"19","author":"T Fraisse","year":"2025","unstructured":"Fraisse T, Putot A, Forestier E, Gavazzi G, Vayne-Bossert P, Roubaud-Baudron C, et al. Antibiotics at life\u2019s end: key role in treating end-of-life pneumonia? Expert Rev Respir Med. 2025;19(4):279\u201386. https:\/\/doi.org\/10.1080\/17476348.2025.2479613.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"7477_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/ice.2018.6","volume":"39","author":"CE Gaw","year":"2018","unstructured":"Gaw CE, Hamilton KW, Gerber JS, Szymczak JE. Physician perceptions regarding antimicrobial use in end-of-life care. Infect Control Hosp Epidemiol. 2018;39(4):383\u201390. https:\/\/doi.org\/10.1017\/ice.2018.6.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"13","key":"7477_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archinternmed.2010.181","volume":"170","author":"JL Givens","year":"2010","unstructured":"Givens JL, Jones RN, Shaffer ML, Kiely DK, Mitchell SL. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med. 2010;170(13):1102\u20137. https:\/\/doi.org\/10.1001\/archinternmed.2010.181.","journal-title":"Arch Intern Med"},{"issue":"2","key":"7477_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1473-3099(04)00931-4","volume":"4","author":"JP Janssens","year":"2004","unstructured":"Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004;4(2):112\u201324. https:\/\/doi.org\/10.1016\/S1473-3099(04)00931-4.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"7477_CR20","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/cid\/ciad735","volume":"78","author":"D Karlin","year":"2024","unstructured":"Karlin D, Pham C, Furukawa D, Kaur I, Martin E, Kates O, et al. State-of-the-art review: use of antimicrobials at the end of life. Clin Infect Dis. 2024;78(3):e27\u201336. https:\/\/doi.org\/10.1093\/cid\/ciad735.","journal-title":"Clin Infect Dis"},{"key":"7477_CR21","doi-asserted-by":"publisher","first-page":"104440","DOI":"10.1016\/j.archger.2021.104440","volume":"96","author":"S Karunananthan","year":"2021","unstructured":"Karunananthan S, Moodie EEM, Bergman H, Payette H, Diehr PH, Wolfson C. Physical function and survival in older adults: a longitudinal study accounting for time-varying effects. Arch Gerontol Geriatr. 2021;96:104440. https:\/\/doi.org\/10.1016\/j.archger.2021.104440.","journal-title":"Arch Gerontol Geriatr"},{"issue":"5","key":"7477_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3904\/kjim.2023.160","volume":"38","author":"MK Kwon","year":"2023","unstructured":"Kwon MK, Jung KH, Choi S, Kim H, Woo CY, Lee M, et al. Antibiotics use patterns in end-of-life cancer patients and medical staff\u2019s perception of antimicrobial stewardship programs. Korean J Intern Med. 2023;38(5):758\u201368. https:\/\/doi.org\/10.3904\/kjim.2023.160.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"7477_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.idc.2022.09.003","volume":"37","author":"J Larnard","year":"2023","unstructured":"Larnard J, Stead W, Branch-Elliman W. Considering patient, family, and provider goals and expectations in a rapidly changing clinical context: a framework for antimicrobial stewardship at the end of life. Infect Dis Clin North Am. 2023;37(1):139\u201351. https:\/\/doi.org\/10.1016\/j.idc.2022.09.003.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"7477_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1378\/chest.09-2757","volume":"138","author":"PD Levin","year":"2010","unstructured":"Levin PD, Simor AE, Moses AE, Sprung CL. End-of-life treatment and bacterial antibiotic resistance: a potential association. Chest. 2010;138(3):588\u201394. https:\/\/doi.org\/10.1378\/chest.09-2757.","journal-title":"Chest"},{"issue":"2","key":"7477_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1049909115611875","volume":"34","author":"ER Manu","year":"2017","unstructured":"Manu ER, Mody L, McNamara SE, Vitale CA. Advance directives and care received by older nursing home residents. Am J Hosp Palliat Care. 2017;34(2):105\u201310. https:\/\/doi.org\/10.1177\/1049909115611875.","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"7477_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1017\/ice.2020.1241","volume":"42","author":"AR Marra","year":"2021","unstructured":"Marra AR, Puig-Asensio M, Balkenende E, Livorsi DJ, Goto M, Perencevich EN. Antibiotic use during end-of-life care: a systematic literature review and meta-analysis. Infect Control Hosp Epidemiol. 2021;42(5):523\u20139. https:\/\/doi.org\/10.1017\/ice.2020.1241.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7488","key":"7477_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.330.7488.383-b","volume":"330","author":"S Mayor","year":"2005","unstructured":"Mayor S. Antibiotic resistance is highest in south and east Europe. BMJ. 2005;330(7488):383.","journal-title":"BMJ"},{"issue":"2","key":"7477_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/IJPC.IJPC_156_18","volume":"25","author":"MI Naharci","year":"2019","unstructured":"Naharci MI, Buyukturan O, Cintosun U, Doruk H, Tasci I. Functional status of older adults with dementia at the end of life: is there still anything to do? Indian J Palliat Care. 2019;25(2):197\u2013202. https:\/\/doi.org\/10.4103\/IJPC.IJPC_156_18.","journal-title":"Indian J Palliat Care"},{"issue":"4","key":"7477_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00520-025-09310-2","volume":"33","author":"C Pala","year":"2025","unstructured":"Pala C, Gamondi C, Eychmuller S, Herrmann F, Pautex S. The use of artificial nutrition at the end-of-life: a cross-sectional survey exploring the beliefs and decision-making among physicians and nurses. Support Care Cancer. 2025;33(4):287. https:\/\/doi.org\/10.1007\/s00520-025-09310-2.","journal-title":"Support Care Cancer"},{"issue":"6","key":"7477_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/jpm.2012.0369","volume":"16","author":"S Pautex","year":"2013","unstructured":"Pautex S, Vayne-Bossert P, Jamme S, Herrmann F, Vilarino R, Weber C, et al. Anatomopathological causes of death in patients with advanced cancer: association with the use of anticoagulation and antibiotics at the end of life. J Palliat Med. 2013;16(6):669\u201374. https:\/\/doi.org\/10.1089\/jpm.2012.0369.","journal-title":"J Palliat Med"},{"issue":"6","key":"7477_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0885-3924(98)00093-1","volume":"16","author":"J Pereira","year":"1998","unstructured":"Pereira J, Watanabe S, Wolch G. A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage. 1998;16(6):374\u201381. https:\/\/doi.org\/10.1016\/S0885-3924(98)00093-1.","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"7477_CR32","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1089\/jpm.2013.0276","volume":"16","author":"JH Rosenberg","year":"2013","unstructured":"Rosenberg JH, Albrecht JS, Fromme EK, Noble BN, McGregor JC, Comer AC, et al. Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med. 2013;16(12):1568\u201374. https:\/\/doi.org\/10.1089\/jpm.2013.0276.","journal-title":"J Palliat Med"},{"issue":"2","key":"7477_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00520-011-1084-1","volume":"20","author":"S Stiel","year":"2012","unstructured":"Stiel S, Krumm N, Pestinger M, Lindena G, Nauck F, Ostgathe C, et al. Antibiotics in palliative medicine\u2014results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer. 2012;20(2):325\u201333. https:\/\/doi.org\/10.1007\/s00520-011-1084-1.","journal-title":"Support Care Cancer"},{"issue":"1","key":"7477_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.2010.1923","volume":"305","author":"S Studenski","year":"2011","unstructured":"Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50\u20138. https:\/\/doi.org\/10.1001\/jama.2010.1923.","journal-title":"JAMA"},{"issue":"2","key":"7477_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jamda.2010.07.001","volume":"13","author":"JT van der Steen","year":"2012","unstructured":"van der Steen JT, Lane P, Kowall NW, Knol DL, Volicer L. Antibiotics and mortality in patients with lower respiratory infection and advanced dementia. J Am Med Dir Assoc. 2012;13(2):156\u201361. https:\/\/doi.org\/10.1016\/j.jamda.2010.07.001.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"7477_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0885-3924(00)00189-5","volume":"20","author":"L Vitetta","year":"2000","unstructured":"Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage. 2000;20(5):326\u201334. https:\/\/doi.org\/10.1016\/S0885-3924(00)00189-5.","journal-title":"J Pain Symptom Manage"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07477-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:57:16Z","timestamp":1783303036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7477"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07477-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study was anonymous and cannot be traced to any individual participant.The study protocol was submitted to the Geneva University Hospitals advisory board for the evaluation of studies not covered by the research ethics committee (CEENCER: Conseil d\u2019Evaluation des Etudes ne Relevant pas de la Commission d\u2019Ethique de la Recherche), which is the institutional review board for studies involving healthcare professionals, and received its approval.Informed consent to participate was obtained from all participants at the beginning of the survey.The study was conducted in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants had to explicitly agree to the use of their anonymous data for publication purposes. All data used in this study was anonymous and cannot be traced to any individual participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"907"}}